Abvc Biopharma Inc share price logo

Abvc Biopharma Inc Share Price

NASDAQ: ABVC

Small Cap

$2.85

-0.02

(-0.70%)

Live

as on

Abvc Biopharma Inc Stock Performance

as on September 17, 2025 at 12:40 am IST

  • Day's Low

    Day's High

    $2.82
    $2.89
    downward going graph

    1.05%

    Downside

    1.40%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.4
    $5.48
    downward going graph

    85.96%

    Downside

    92.28%

    Upside

    downward going graph

Abvc Biopharma Inc share price movements today

Previous Close
$2.87
Open
$2.85
Volume
228.2K
Day's Low - High
$2.82 - $2.89
52 Week Low - High
$0.4 - $5.48

Abvc Biopharma Inc Historical Returns

1 Month Return
-13.03 %
3 Month Return
+ 47.18 %
1 Year Return
+ 324.56 %
3 Year Return
-60.68 %
5 Year Return
0 %

Abvc Biopharma Inc Stock Fundamentals & Key Indicators

Check Abvc Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$67.1M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-4.0M

Revenue (TTM)

391.2K

Profit Margin

0.00%

Return On Equity TTM

73262700.00%

Abvc Biopharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Abvc Biopharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Abvc Biopharma Inc image
Abvc Biopharma Inc
SELL$67.1MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$61.1B251.26%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$38.7BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$101.2B47.46%28.0931.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.6B0.6%14.131.37%

Stock Returns calculator for Abvc Biopharma Inc Stock including INR - Dollar returns

The Abvc Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Abvc Biopharma Inc investment value today

Current value as on today

₹4,23,985

Returns

₹3,23,985

(+323.99%)

Returns from Abvc Biopharma Inc Stock

₹3,19,118 (+319.12%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Abvc Biopharma Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Abvc Biopharma Inc. Average target price of $2.02

Abvc Biopharma Inc Share Price Target

Get share price movements and forecasts by analysts on Abvc Biopharma Inc.

What analysts predicted

-41.09%DOWNSIDE

Target Price

$2.02

Current Price

$2.85

Analyzed by

6 Analysts

Target

$2.02

Abvc Biopharma Inc target price $2.02, a slight downside of -41.09% compared to current price of $2.85. According to 6 analysts rating.

Abvc Biopharma Inc Stock's Interest Amongst Investors

Search interest for Abvc Biopharma Inc Stock has increased by 44% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:44% versus previous 30 day period

Abvc Biopharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
0
0
0
0
0
0
0
0
0
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-1
-2
-2
-1
-2
0
0
0
0
-2
EBITDA
-1
-2
-2
-2
-2
-1
0
-
0
-2
Interest Expense
0
0
1
1
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-2
-3
-3
-2
-1
0
0
0
-2
Income Tax Expense
-1
0
0
0
-3
0
0
-
-
0
Net Income
-1
-2
-3
-3
-2
-1
0
0
0
-2
Net Profit Margin
-1421.74%
-37060.08%
-20888.94%
-143695.15%
-235203.24%
-864.76%
-47.93%
11663.48%
-42849.87%
0.00%

Abvc Biopharma Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Sep 2017
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
-
0
0
0
0
0
0
0
0
Gross Profit
0
-
0
0
0
0
0
0
0
0
Operating Income
-10
-
-4
-1
-3
-8
-11
-15
-6
-4
EBITDA
0
-
-3
-2
-3
-10
-10
-15
-6
-4
Interest Expense
0
-
0
0
0
0
0
0
1
0
Depreciation
-
-
0
-
0
0
0
0
0
0
Income Before Tax
-4
-
-7
-6
-4
-10
-11
-15
-8
-5
Income Tax Expense
0
-
0
0
0
0
0
0
0
0
Net Income
-4
-4
-5
-4
-3
-9
-12
-16
-7
-4
Net Profit Margin
-14086871.88%
0.00%
-157947.43%
-58956.30%
-519.01%
-2026.93%
-3608.52%
-1693.47%
-5109.23%
-962.15%

Abvc Biopharma Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-2
-3
-3
-2
-1
0
0
0
-2
Operating Cash Flow
0
-1
0
0
-1
0
0
0
0
Investing Cash Flow
0
0
0
-
-
-
-
-
0
Financing Cash Flow
0
1
0
0
0
0
0
0
1
Change in Cash
-1
0
0
0
0
0
0
0
0

Abvc Biopharma Inc Annual Cash Flow

All numbers in Millions USD

Sep 2017
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-4
-6
-4
-3
-10
-12
-16
-10
-5
Operating Cash Flow
-1
-1
0
-3
-4
-7
-7
-4
-1
Investing Cash Flow
0
-7
0
0
0
0
-1
0
-
Financing Cash Flow
1
9
0
3
9
9
4
3
1
Change in Cash
0
0
0
0
4
1
-5
0
0

Global Institutional Holdings in Abvc Biopharma Inc

Funds
Holdings
Geode Capital Management, LLC
0.62%
XTX Topco Ltd
0.36%
Vanguard Group Inc
0.28%
UBS Group AG
0.17%
Northern Trust Corp
0.11%
See all

Insights on Abvc Biopharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ABVC has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 177.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 389.27K → 1.96K (in $), with an average decrease of 49.8% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, ABVC stock has moved down by -13.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 229.30K → -2.25M (in $), with an average decrease of 317.6% per quarter

About Abvc Biopharma Inc

american brivision (holding) corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the united states. the company is developing abv-1501, a combination therapy for triple negative breast cancer; abv-1504 for major depressive disorders; abv-1505 for attention deficit hyperactivity disorder; abv-1703 for the treatment of pancreatic cancer; abv-1702 to treat myelodysplastic syndromes; and abv-1601 for treating depression in cancer patients. it has a co-development agreement with rgene corporation; collaboration agreement with biohopeking corporation to develop abv-1501; and collaborative agreement with biofirst corporation to co-develop bfc-1401 vitreous substitute for vitrectom; and license with biofirst corporation to research and develop a medical device, abv-1701 vitargus for the treatment of retinal detachment or vitreous hemorrhage. the company was founded in 2015 and is based in fremont, california. american br
OrganisationAbvc Biopharma Inc
Headquarters44370 Old Warm Springs Boulevard, Fremont, CA, United States, 94538
IndustryIndustrial Specialties
CEODr. Uttam Yashwant Patil Ph.D.
E-voting on sharesClick here to vote

Key Management of Abvc Biopharma Inc

Name

Title

Dr. Uttam Yashwant Patil Ph.D.

CEO & Interim CFO

Dr. Tsung-Shann Jiang EMBA, Ph.D.

Chief Scientific Officer, Chief Strategy Officer & Director

Mr. Eugene Jiang

Chairman & Chief Business Officer

FAQs

What is Abvc Biopharma Inc share price today?

Abvc Biopharma Inc share price today is $2.85 as on . Abvc Biopharma Inc share today touched a day high of $2.89 and a low of $2.82.

What is the 52 week high and 52 week low for Abvc Biopharma Inc share?

Abvc Biopharma Inc share touched a 52 week high of $5.48 on and a 52 week low of $0.4 on . Abvc Biopharma Inc stock price today i.e. is trending at $2.85,which is 47.99% down from its 52 week high and 612.50% up from its 52 week low.

What is Abvc Biopharma Inc's market capitalisation today?

Abvc Biopharma Inc market capitalisation is $0.00T as on .

How to invest in Abvc Biopharma Inc Stock (ABVC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Abvc Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abvc Biopharma Inc Shares that will get you 0.5263 shares as per Abvc Biopharma Inc share price of $2.85 per share as on September 17, 2025 at 12:40 am IST.

What is the minimum amount required to buy Abvc Biopharma Inc Stock (ABVC) from India?

Indian investors can start investing in Abvc Biopharma Inc (ABVC) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Abvc Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Abvc Biopharma Inc share’s latest price of $2.85 as on September 17, 2025 at 12:40 am IST, you will get 3.5088 shares of Abvc Biopharma Inc. Learn more about fractional shares .